MedPath

se-results survey for Lonsurf combination tablet T15 & Lonsurf combination tablet T20

Not Applicable
Completed
Conditions
Colorectal cancer
Registration Number
JPRN-jRCT1080222608
Lead Sponsor
Taiho Pharmaceutical Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
800
Inclusion Criteria

Unresectable advanced or recurrent colorectal cancer (only if refractory to standard treatments).

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath